Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression

PLoS ONE

Volumn 3, Issue 1, 2008, Pages

  Karam, Farba ^a   Mbow, Fatou ^b   Fletcher, Helen ^c   Senghor, Cheikh S ^d   Coulibaly, Koura D ^d   LeFevre, Andrea M ^e   Ngom Gueye, Ndeye F ^d   Dieye, Tandakha ^a   Sow, Papa S ^d   Mboup, Souleymane ^a   Lienhardt, Christian ^b,f  

^a Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Hospitalier Universitaire de Fann   (Senegal)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL ANTIGEN; BCG VACCINE; CD4 ANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; PEPTIDE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLONAL ANERGY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FRANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TUBERCULIN TEST; TUBERCULOSIS; VALIDATION STUDY; VIRUS STRAIN; AIDS RELATED COMPLEX; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 39049167027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001441     Document Type: Article

References (33)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282(7): 677-86.
2. Corbett EL, Watt CJ, Walker N, Maher D, William BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163(9): 1009-21.
3. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, et al. (1995) Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Grit Care Med 151(1): 129-35.
4. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, et al. (2005) How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 191(2): 150-8.
5. World Health Organization (2004) Interim policy on collaborative TB/HIV activities. Geneva: WHO;WHO/HTM/TB/2004.330).
6. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17(6): 968-75.
7. Shafer RW, Edlin BR (1996) Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 22(4): 683-704.
8. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235): 1099-104.
9. Ulrichs T, Anding P, Porcelli S, Kaufmann SH, Munk ME (2000) Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun 68(10): 6073-6.
10. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40(2): 704-6.
11. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, et al. (2001) Enumeration of T cells specific for RDI-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183(3): 469-77.
12. Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, et al. (2004) Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 38(7): 966-73.
13. Elliott AM, Hurst TJ, Balyeku MN, Quigley MA, Kaleebu P, et al. (1999) The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 3(3): 239-47.
14. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, et al. (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16(17): 2285-93.
15. Ministère de la Santé et de la Prévention du Senegal (2002) HIV/ AIDS surveillance programme. Bulletin Epidémiologique No9;Dakar, Sénégal.
16. Thiam S, Massi E, Ndir M, Diop AH, Ba F, et al, (2005) [Tuberculosis control in Senegal: update on care services and recommendations for improvement]. Med Trop 65(1): 43-8.
17. Dieye TN, Vereecken C, Diallo AA, Ondoa P, Diaow PA, et al. (2005) Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr 39(1): 32-7.
18. Lalvani A, Brookes R, Wilkinson RJ, Malin AS; Pathan AA, et al. (1998) Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobarterium tuberculosis. Proc Natl Acad Sci U.S.A 95(1): 270-5.
19. Dheda K, Lalvani A, Miller RF, Scott G, Booth, H, et al. (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count AIDS 19(17): 2038-41.
20. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327: 307-10.
21. Bland JM, Altman DG (1995) Comparirg methods of measurement: why plotting difference against standard method is misleading. Lancet 346: 1085-1087.
22. Madhi SA, Gray GE, Huebner RE, Sherman G, McKinnon D, Pettifor JM (1999) Correlation between CD4+ lymphocytes counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1 and uninfected children with tuberculosis. Pediatr Infect Dis J 18(9): 800-5.
23. Palme IB, Cudetta B, Bruchfeld J, Muhe L, Giesecke J (2002) Impact of human immuno-deficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohor of Ethiopian children with tuberculosis. Pediatr Infect Dis J 21(11): 1053-61.
24. Arend, SM, Engelhard AC, Groot G, de Boer K, Andersen P, et al. (2001) Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons vith recent tuberculosis contact. Clin Diagn Lab Immunol 8(6): 1089-96.
25. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361(9364): 1168-73.
26. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R (2007) T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infectious Diseases.
27. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the Diagnosis of, Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. Ann Intern Med 146: 340-351.
28. Garcia-Garcia MI, Valdespino-Gomez JL, Garcia-Sancho C, Mayar-Maya ME, Ferreyra-Reyes L, et al. (2000) Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects. Int J Epidemiol 29(2): 369-75.
29. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P (2006) Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test. Respiratory Research 7: 56.
30. Roffmann M, Reichmuth M, Fantelli K, Schoch OD, Fierz W, et al. (2007) Conventional tuberculin skin testing versus T cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS 21, 390-392.
31. Sutherland R, Yang H, Scriba TJ, Ondondo B, Robinson B, et al. (2005) Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS 20(6): 821-29.
32. Lienharch C, Fielding Y, Sillah J, Tunkara A, Donkor S, et al. (2003) Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia. Am J Respir Crit Care Med 168(4): 448-55.
33. Kanki PJ, Travers KU, Mboup S, Hsieh CC, Maclink RG, et al. (1994) Slower heterosexual spread of HIV2 than HIV1. Lancet 343(8903): 941-6.